An innovative light-based technique could revolutionize the early detection of prostate cancer, claims new Aston University research presented in Scientific Reports. The research team led by Professor Igor Meglinski from Aston’s Institute of Photonic Technologies is behind the development of the pioneering method, which promises faster, less invasive and more affordable diagnostic procedures than existing methods.
Light technology in the service of cancer detection
The team of dr. Meglinski used a new polarization-based image reconstruction technique to examine polycrystalline structures in dehydrated blood samples. During the early stages of diseases such as cancer, proteins in the blood change their shape and arrangement. The researchers focused on these changes in both tertiary structure (the unique three-dimensional shape of an individual protein) and quaternary structure (the way multiple proteins bind together) to detect and sort cells. This innovative method enabled an in-depth, detailed analysis of dried blood smears, allowing the identification of critical differences between healthy and cancer cells.
The study involved the analysis of 108 blood samples that were divided into three groups:
- healthy people,
- prostate cancer patients and
- people with a more aggressive form of the disease.
The findings were remarkable, with the technique achieving a 90% accuracy rate in both early diagnosis and classification of cancer, significantly outperforming existing screening methods. One of the key advantages of this new approach is that it relies on blood samples rather than tissue biopsies, which makes it less painful and dangerous for patients.
“Our study introduces a pioneering technique, aligned with the ongoing search for non-invasive, reliable and effective diagnostic methods,” said Dr. Meglinski. “An important advance is the characterization of the mean, variance, skewness, and kurtosis of the distributions within cells, which is crucial for identifying significant differences between healthy and cancer samples.”
New possibilities in cancer diagnosis
The implications of this research are profound. The high accuracy of this technique, combined with its non-invasive nature, is a significant advance in the diagnostic process. It can revolutionize cancer diagnosis, early detection, stratification and follow-up, significantly improving patient care and treatment outcomes.
“This discovery opens new avenues for cancer diagnosis and monitoring, representing a substantial leap forward in personalized medicine and oncology,” said Dr. Meglinski, judging that as this technique evolves, it could become a critical tool in the fight against cancer.
Read also:
Where is the “Floka” Processing Plant: New data on garbage, structural changes are coming
Etoloakarnania: Lightning killed more than 150 animals in a livestock farm PHOTO
Ukraine: 7 dead in the city of Lviv after a Russian missile attack, three children among them PHOTO VIDEO
Weather – Kolydas: In which areas are storms expected until Sunday, from Monday the first autumn system with lots of rain
France: The daughter of the 72-year-old who organized her rape by strangers is shocked VIDEO
#Innovative #technique #detects #disease #early #accuracy
Prostate cancer prevention sexually active
Table of Contents
Revolutionizing Prostate Cancer Detection: A New Light-Based Technique
Prostate cancer is one of the most common types of cancer affecting men worldwide. Early detection is crucial in improving treatment outcomes and saving lives. The current screening methods for prostate cancer include the prostate-specific antigen (PSA) test and the digital rectal exam (DRE) [[1]][[2]]. However, these methods have limitations, and researchers have been searching for more accurate and less invasive diagnostic procedures. Recent research from Aston University presents a groundbreaking light-based technique that could revolutionize the early detection of prostate cancer.
The Innovative Technique
The research team, led by Professor Igor Meglinski, has developed a pioneering method that uses a new polarization-based image reconstruction technique to examine polycrystalline structures in dehydrated blood samples. During the early stages of diseases like cancer, proteins in the blood change their shape and arrangement. The researchers focused on these changes in both tertiary structure (the unique three-dimensional shape of an individual protein) and quaternary structure (the way multiple proteins bind together) to detect and sort cells. This innovative method enabled an in-depth, detailed analysis of dried blood smears, allowing the identification of critical differences between healthy and cancer cells.
The Study’s Findings
The study involved the analysis of 108 blood samples that were divided into three groups: healthy people, prostate cancer patients, and people with a more aggressive form of the disease. The findings were remarkable, with the technique achieving a 90% accuracy rate in both early diagnosis and classification of cancer, significantly outperforming existing screening methods. One of the key advantages of this new approach is that it relies on blood samples rather than tissue biopsies, which makes it less painful and dangerous for patients.
New Possibilities in Cancer Diagnosis
The implications of this research are profound. The high accuracy of this technique, combined with its non-invasive nature, is a significant advance in the diagnostic process. It can revolutionize cancer diagnosis, early detection, stratification, and follow-up, significantly improving patient care and treatment outcomes. As this technique evolves, it could become a critical tool in the fight against cancer, representing a substantial leap forward in personalized medicine and oncology.
The Future of Prostate Cancer Detection
This innovative light-based technique has the potential to revolutionize the early detection of prostate cancer, providing a faster, less invasive, and more affordable diagnostic procedure than existing methods. With its high accuracy rate and non-invasive nature, it could become a critical tool in the fight against cancer, improving patient care and treatment outcomes. As research continues to advance, we may see a significant shift in the way prostate cancer is detected and treated, leading to better health outcomes for patients worldwide.
References:
[[1]]https://www.pcf.org/about-prostate-cancer/diagnosis-staging-prostate-cancer/screening-early-detection/
[[2]]https://www.mskcc.org/cancer-care/types/prostate/diagnosis
[[3]]https://www.nhs.uk/conditions/prostate-cancer/diagnosis/
Prostate cancer prevention sexually active
Revolutionizing Prostate Cancer Detection: A New Light-Based Technique
Prostate cancer is one of the most common types of cancer affecting men worldwide. Early detection is crucial in improving treatment outcomes and saving lives. The current screening methods for prostate cancer include the prostate-specific antigen (PSA) test and the digital rectal exam (DRE) [[1]][[2]]. However, these methods have limitations, and researchers have been searching for more accurate and less invasive diagnostic procedures. Recent research from Aston University presents a groundbreaking light-based technique that could revolutionize the early detection of prostate cancer.
The Innovative Technique
The research team, led by Professor Igor Meglinski, has developed a pioneering method that uses a new polarization-based image reconstruction technique to examine polycrystalline structures in dehydrated blood samples. During the early stages of diseases like cancer, proteins in the blood change their shape and arrangement. The researchers focused on these changes in both tertiary structure (the unique three-dimensional shape of an individual protein) and quaternary structure (the way multiple proteins bind together) to detect and sort cells. This innovative method enabled an in-depth, detailed analysis of dried blood smears, allowing the identification of critical differences between healthy and cancer cells.
The Study’s Findings
The study involved the analysis of 108 blood samples that were divided into three groups: healthy people, prostate cancer patients, and people with a more aggressive form of the disease. The findings were
